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CARDIAC SURGERY: JUST
A MARKER OF DISEASE
SEVERITY STRONGLY
RELATED TO AGE OR MUCH
MORE?
To the Editor:
We read with interest the article of
Radman and colleagues1 entitled,
‘‘The effect of preoperative nutritional
status on postoperative outcomes in
children undergoing surgery for
congenital heart defects in San Fran-
cisco (UCSF) and Guatemala City
(UNICAR),’’ recently published in
the Journal. We agree with Radman
and colleagues1 that body fat mass
and acute and chronicmalnourishment
are important determinants of worse
outcome in children undergoing
surgery1-4; the relationship of
these factors to preoperative B-type
natriuretic peptide (BNP) values,
however, merits further consideration.
Actually, Radman and colleagues1
included in their study a wideThe Journalspectrum of ages (interquartile range,
3.2-47.1 months) and congenital heart
diseases (from simple septal defects to
univentricular heart). It has been
widely demonstrated that preopera-
tive BNP values as well as postopera-
tive BNP variations should be
interpreted as the consequences of 2
major factors: disease severity and
age.2,3 The influence of these
variables is particularly remarkable
in the neonatal and infant setting,
because neonatal cardiac surgery
usually carries a higher surgical risk
as a result of the severity of the
disease2-4 and many maturational
variations in endocrine function
within the first month of life.2,3 The
cardiac natriuretic peptide system is
a relevant component of a complex
and integrated network that includes
the endocrine, nervous, and immune
systems.5 For the same age and dis-
ease severity, a huge number of bio-
logic substances, environmental
factors, and physiologic parameters
contribute to BNP response5; body
fat mass and malnutrition are only 2
factors among these. Unfortunately,
the small sample size (only 71 pa-
tients) of the study by Radman and
colleagues1 does not allow a risk strat-
ification analysis that includes all
these parameters. In particular, low
body fat mass and malnutrition,
frequently observed in children with
more severe cardiac defects,1,4 are
important factors that contribute to
the severity of the disease state and
in turn to the rise in BNP values.
In conclusion, recent data support
the use of BNP as a useful adjunct
prognostic and disease severity
marker in children undergoing cardiac
surgery. Both preoperative values and
postsurgical variations in BNP should
be interpreted first according to age
and disease severity2,3 and only
secondarily as the consequence of
additional factors, including
malnutrition and body fat mass.
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REPEATING ITSELF? AWORD
OF CAUTION
To the Editor:
Current practice guidelines require
that transcatheter aortic valve implan-
tation (TAVI) be performed by a heart
team composed of interventional car-
diologists and surgeons in a hybrid
operating room.1 The occurrence of
a case, treated in a hospital without
cardiac surgery on site, in which the
implanted prosthesis migrated into
the left ventricle and required surgical
removal, prompted this report.
A 69-year-old woman underwent
TAVI in a facility without on-site car-
diac surgery. Shortly after transfe-
moral implantation, the prosthesisry c Volume 147, Number 1 541
Letters to the Editormigrated into the left ventricle.
Because of hemodynamic instability,
our cardiac surgery team intervened
locally and placed the patient on
extracorporeal membrane oxygena-
tion, before transferring her to our
institution, where she underwent
aortic valve replacement. After a
complicated course, she was sent to
a rehabilitation facility in good
condition.
During the late 1980s and the
beginning of the 1990s, at the onset
of the coronary interventional era, all
procedures were performed only in in-
stitutions with cardiac surgery on site
and strictly with surgical standby.
Later, with the increasing confidence
of the interventional cardiologists,
more sophisticated technology, and a
very low need for surgical rescue,
the procedure also gained widespread
application in hospitals without car-
diac surgery on site.
Similarly, because the need for sur-
gical rescue has been low in all series,
it is understandable that some inter-
ventional cardiologists have been
tempted to perform TAVI without sur-
gical standby. Approximately one
third of centers performing TAVI in
Germany do not have cardiac surgery
on site, and in Italy, at least 1 other
institution currently performs TAVI
without cardiac surgery on standby.
Not surprisingly, the invasive cardi-
ologists are already in turmoil, and the
discussion on whether TAVI can be
performed without on-site cardiac sur-
gery has been continuing in the pub-
lished studies. In response to a plea
for a same-institution interdisci-
plinary approach,2 Eggebrecht and
colleagues3 cautioned against consid-
ering the use of the heart team concept
as being synonymous with an on-site
cardiac surgery program. They also
claimed that some centers have
embraced a different ‘‘heart team’’
interpretation by collaborating with
cardiac surgeons who would come to
their hospitals, participate in the pro-
cedure, and rescue the patient when
complications occurred.3542 The Journal of Thoracic and CThrough our experiencewith the pa-
tient we have described, others would
now argue that, provided the expertise
is available to promptly institute extra-
corporealmembrane oxygenation, this
could be another acceptable method to
salvage patients with complicated
cases. Finally, let us not forget that
the entire dispute could become
merely academic if someone asked
why bother to try to rescue, with slight
chances of success, that very rare pa-
tient already deemed inoperable by
the surgeon from the beginning. Our
patient’s good outcome was probably
more the exception than the rule.
Notwithstanding any of these argu-
ments, we and the surgical community
remain convinced that to achieve the
best possible result, any major
complication should be managed by
a surgical team immediately after the
occurrence and that any other creative
arrangements can only put the pa-
tient’s life at greater risk and subject
the hospital and operating team to a
malpractice suit. That statement be-
comes even more persuasive if we
look at the future, when this procedure
could be offered to an increasing num-
ber of patients who are low-risk surgi-
cal candidates.
Accordingly, the recent European
Society of Cardiology/European As-
sociation for Cardio-Thoracic Surgery
guidelines4 have considered the
absence of cardiac surgery on site a
contraindication. Hopefully, also in
Europe and Italy, just as in the United
States, procedure reimbursement will
be authorized only for those institu-
tions at which TAVIs are performed
in an interventional suite or hybrid
operating room by a heart team.
Only then we could consider applying
this revolutionary procedure even in
lower risk patients.
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AORTIC VALVE
ENDOCARDITIS
To the Editor:
It was with great interest that we
read the article by Heinz and col-
leagues1 reporting the long-term out-
comes after Freestyle (Medtronic
Inc, Minneapolis, Minn) root replace-
ment for complex destructive aortic
valve endocarditis. They included 32
patients (median age, 61 years) who
underwent the procedure between
1997 and 2012 and found that 5-year
survival was 62%, and 5-year
freedom from short- and long-term
cardiac events was 56%. They
concluded that the Freestyle xenograft
is a comparable alternative to homo-
graft for treatment of complex aortic
valve endocarditis.
We congratulate Heinz and col-
leagues on their excellent results in a
challenging patient group and we
wish to offer some additional data
supporting the use of the Freestyle
